These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27845774)

  • 21. Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis.
    Basoglu C; Oner O; Gunes C; Semiz UB; Ates AM; Algul A; Ebrinc S; Cetin M; Ozcan O; Ipcioglu O
    Int Clin Psychopharmacol; 2010 May; 25(3):165-71. PubMed ID: 21811193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
    Bond DJ; Kauer-Sant'Anna M; Lam RW; Yatham LN
    J Affect Disord; 2010 Jul; 124(1-2):108-17. PubMed ID: 19914720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity, diabetes, and the metabolic syndrome: new challenges in antipsychotic drug therapy.
    Caballero E
    CNS Spectr; 2003 Nov; 8(11 Suppl 2):19-22. PubMed ID: 14978454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis.
    Verma S; Liew A; Subramaniam M; Poon LY
    Aust N Z J Psychiatry; 2009 Sep; 43(9):812-7. PubMed ID: 19670054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome and atypical antipsychotics: Possibility of prediction and control.
    Franch Pato CM; Molina Rodríguez V; Franch Valverde JI
    Rev Psiquiatr Salud Ment; 2017; 10(1):38-44. PubMed ID: 27939025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
    Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
    Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
    Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
    J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gaining: pediatric patients and use of atypical antipsychotics.
    Towbin KE
    Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolic screening for patients with second-generation antipsychotic medication: A population-based study from 2004 to 2016.
    Lee EHM; Hui CLM; Law EYL; Chan PY; Chang WC; Chan SKW; Chen EYH
    Schizophr Res; 2018 Jul; 197():618-619. PubMed ID: 29477247
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic issues in psychotic disorders with the focus on first-episode patients: a review.
    Britvic D; Maric NP; Doknic M; Pekic S; Andric S; Jasovic-Gasic M; Popovic V
    Psychiatr Danub; 2013 Dec; 25(4):410-5. PubMed ID: 24247054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
    Strassnig M; Miewald J; Keshavan M; Ganguli R
    Schizophr Res; 2007 Jul; 93(1-3):90-8. PubMed ID: 17478082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment.
    Kriisa K; Leppik L; Balõtšev R; Ottas A; Soomets U; Koido K; Volke V; Innos J; Haring L; Vasar E; Zilmer M
    J Proteome Res; 2017 Oct; 16(10):3558-3566. PubMed ID: 28786289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring and Treating Metabolic Abnormalities in Patients with Early Psychosis Initiated on Antipsychotic Medications.
    Bozymski KM; Whitten JA; Blair ME; Overley AM; Ott CA
    Community Ment Health J; 2018 Aug; 54(6):717-724. PubMed ID: 29127566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
    Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
    Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The medical care of people with psychosis.
    Lambert TJ
    Med J Aust; 2009 Feb; 190(4):171-2. PubMed ID: 19220177
    [No Abstract]   [Full Text] [Related]  

  • 40. No mental health without physical health.
    Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
    Lancet; 2011 Feb; 377(9766):611. PubMed ID: 21334517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.